Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
Title:
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
Author:
Ravnborg, Mads Sørensen, Per Soelberg Andersson, Magnus Celius, Elisabeth G Jongen, Peter J Elovaara, Irina Bartholomé, Emmanuel Constantinescu, Cris S Beer, Karsten Garde, Ellen Sperling, Bjørn